Pfizer and Acura Announce FDA Approval of Oxecta
Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM (oxycodone HCl, USP) Tablets CII. OXECTA is indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.
FDA Approves Pain Reliever Abstral for Cancer Patients
The FDA has approved the use of Abstral for additional pain relief in cancer patients. The drug is an immediate release medication designed to help individuals already on regular opioid pain treatment.